{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:00:14Z","timestamp":1758052814425,"version":"3.44.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["R01 HD093612"],"award-info":[{"award-number":["R01 HD093612"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chemico-Biological Interactions"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.cbi.2022.110228","type":"journal-article","created":{"date-parts":[[2022,10,22]],"date-time":"2022-10-22T10:52:02Z","timestamp":1666435922000},"page":"110228","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Involvement of esterases in the pulmonary metabolism of beclomethasone dipropionate and the potential influence of cannabis use"],"prefix":"10.1016","volume":"368","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8986-2189","authenticated-orcid":false,"given":"Yuli","family":"Qian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip W.","family":"Melchert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cbi.2022.110228_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss7005a1","article-title":"Asthma surveillance - United States, 2006-2018","volume":"70","author":"Pate","year":"2021","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.cbi.2022.110228_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1164\/ajrccm.157.3.157315","article-title":"Efficacy and safety of inhaled corticosteroids. New developments","volume":"157","author":"Barnes","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cbi.2022.110228_bib3","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.jaci.2007.09.029","article-title":"Expert panel report 3 (EPR-3): guidelines for the diagnosis and management of asthma-summary report 2007","volume":"120","year":"2007","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2022.110228_bib4","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.jaci.2020.10.003","article-title":"Focused updates to the asthma management guidelines: a report from the national asthma education and prevention program coordinating committee expert panel working group","volume":"146","author":"Cloutier","year":"2020","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.cbi.2022.110228_bib5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/bdd.2510110503","article-title":"Activation of beclomethasone dipropionate by hydrolysis to beclomethasone-17-monopropionate","volume":"11","author":"Wurthwein","year":"1990","journal-title":"Biopharm. Drug Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib6","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.0306-5251.2001.01374.x","article-title":"Beclomethasone dipropionate: absolute bioavailability, pharmacokinetics and metabolism following intravenous, oral, intranasal and inhaled administration in man","volume":"51","author":"Daley-Yates","year":"2001","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110228_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00228-002-0466-1","article-title":"Pharmacokinetics of beclomethasone 17-monopropionate from a beclomethasone dipropionate extrafine aerosol in adults with asthma","volume":"58","author":"Harrison","year":"2002","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110228_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1465-9921-8-65","article-title":"In vitro metabolism of beclomethasone dipropionate, budesonide, ciclesonide, and fluticasone propionate in human lung precision-cut tissue slices","volume":"8","author":"Nave","year":"2007","journal-title":"Respir. Res."},{"key":"10.1016\/j.cbi.2022.110228_bib9","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1023\/A:1007591624451","article-title":"Metabolism kinetics of beclomethasone propionate esters in human lung homogenates","volume":"17","author":"Foe","year":"2000","journal-title":"Pharm. Res. (N. Y.)"},{"key":"10.1016\/j.cbi.2022.110228_bib10","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.2042-7158.1984.tb04868.x","article-title":"Biotransformation of the topical glucocorticoids budesonide and beclomethasone 17 alpha,21-dipropionate in human liver and lung homogenate","volume":"36","author":"Andersson","year":"1984","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110228_bib11","first-page":"469","article-title":"Comparative pharmacology, bioavailability, pharmacokinetics, and pharmacodynamics of inhaled glucocorticosteroids","volume":"25","author":"Hubner","year":"2005","journal-title":"Immunol. Allergy Clin."},{"key":"10.1016\/j.cbi.2022.110228_bib12","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bcp.2018.01.028","article-title":"Presence and inter-individual variability of carboxylesterases (CES1 and CES2) in human lung","volume":"150","author":"Gabriele","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110228_bib13","doi-asserted-by":"crossref","first-page":"412","DOI":"10.3390\/molecules13020412","article-title":"Structure and catalytic properties of carboxylesterase isozymes involved in metabolic activation of prodrugs","volume":"13","author":"Hosokawa","year":"2008","journal-title":"Molecules"},{"key":"10.1016\/j.cbi.2022.110228_bib14","doi-asserted-by":"crossref","first-page":"4114","DOI":"10.1021\/acs.molpharmaceut.0c00559","article-title":"Characterization of differential tissue abundance of major non-CYP enzymes in human","volume":"17","author":"Basit","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.cbi.2022.110228_bib15","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jprot.2019.03.005","article-title":"Label-free absolute protein quantification with data-independent acquisition","volume":"200","author":"He","year":"2019","journal-title":"J. Proteonomics"},{"key":"10.1016\/j.cbi.2022.110228_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1124\/dmd.120.000065","article-title":"Natural products as modulators of CES1 activity","volume":"48","author":"Qian","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib17","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1124\/dmd.119.089680","article-title":"Carboxylesterase 1 and precision pharmacotherapy: pharmacogenetics and nongenetic regulators","volume":"48","author":"Her","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib18","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1124\/dmd.107.015966","article-title":"A comparison of the expression and metabolizing activities of phase I and II enzymes in freshly isolated human lung parenchymal cells and cryopreserved human hepatocytes","volume":"35","author":"Somers","year":"2007","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib19","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1124\/dmd.118.086074","article-title":"Vitro inhibition of carboxylesterase 1 by major cannabinoids and selected metabolites","volume":"47","author":"Qian","year":"2019","journal-title":"Drug Metab. Dispos."},{"year":"2020","series-title":"NSDUH Detailed Tables [SAMHSA Website]","key":"10.1016\/j.cbi.2022.110228_bib20"},{"key":"10.1016\/j.cbi.2022.110228_bib21","first-page":"180","article-title":"Medicinal cannabis: history, pharmacology, and implications for the acute care setting","volume":"42","author":"Bridgeman","year":"2017","journal-title":"P T"},{"key":"10.1016\/j.cbi.2022.110228_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1513\/AnnalsATS.201407-333OC","article-title":"The effects of marijuana exposure on expiratory airflow. A study of adults who participated in the U.S. National Health and Nutrition Examination Study","volume":"12","author":"Kempker","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.cbi.2022.110228_bib23","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00602-21","article-title":"Key metabolic enzymes involved in remdesivir activation in human lung cells","volume":"65","author":"Li","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.cbi.2022.110228_bib24","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.ajhg.2008.04.015","article-title":"Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis","volume":"82","author":"Zhu","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cbi.2022.110228_bib25","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1124\/dmd.120.000073","article-title":"Predicting the potential for cannabinoids to precipitate pharmacokinetic drug interactions via reversible inhibition or inactivation of major cytochromes P450","volume":"48","author":"Bansal","year":"2020","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1124\/dmd.118.085548","article-title":"Hepatic enzymes relevant to the disposition of (-)-(9)-Tetrahydrocannabinol (THC) and its psychoactive metabolite, 11-OH-THC","volume":"47","author":"Patilea-Vrana","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib27","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1124\/jpet.112.202556","article-title":"Metabolism of beclomethasone dipropionate by cytochrome P450 3A enzymes","volume":"345","author":"Roberts","year":"2013","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2022.110228_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-3565(24)29543-4","article-title":"Application of the relative activity factor approach in scaling from heterologously expressed cytochromes p450 to human liver microsomes: studies on amitriptyline as a model substrate","volume":"297","author":"Venkatakrishnan","year":"2001","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2022.110228_bib29","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0163-7258(99)00028-5","article-title":"The use of heterologously expressed drug metabolizing enzymes--state of the art and prospects for the future","volume":"84","author":"Crespi","year":"1999","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.cbi.2022.110228_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108914","article-title":"The influence of carboxylesterase 1 polymorphism and cannabidiol on the hepatic metabolism of heroin","volume":"316","author":"Qian","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2022.110228_bib31","doi-asserted-by":"crossref","first-page":"862","DOI":"10.3109\/00498254.2015.1133867","article-title":"Esterase phenotyping in human liver in vitro: specificity of carboxylesterase inhibitors","volume":"46","author":"Umehara","year":"2016","journal-title":"Xenobiotica"},{"key":"10.1016\/j.cbi.2022.110228_bib32","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1124\/dmd.110.034249","article-title":"Involvement of carboxylesterase 1 and 2 in the hydrolysis of mycophenolate mofetil","volume":"38","author":"Fujiyama","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib33","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/dmd.113.056184","article-title":"Indiplon is hydrolyzed by arylacetamide deacetylase in human liver","volume":"42","author":"Shimizu","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib34","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1124\/dmd.109.026567","article-title":"Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis","volume":"37","author":"Watanabe","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib35","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1124\/dmd.114.056994","article-title":"Screening of specific inhibitors for human carboxylesterases or arylacetamide deacetylase","volume":"42","author":"Shimizu","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib36","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.cbi.2012.10.018","article-title":"Inhibition of human carboxylesterases hCE1 and hiCE by cholinesterase inhibitors","volume":"203","author":"Tsurkan","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.cbi.2022.110228_bib37","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1021\/jm049011j","article-title":"Identification and characterization of novel benzil (diphenylethane-1,2-dione) analogues as inhibitors of mammalian carboxylesterases","volume":"48","author":"Wadkins","year":"2005","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.cbi.2022.110228_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2019.104199","article-title":"Discovery of natural pentacyclic triterpenoids as potent and selective inhibitors against human carboxylesterase 1","volume":"137","author":"Song","year":"2019","journal-title":"Fitoterapia"},{"key":"10.1016\/j.cbi.2022.110228_bib40","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1124\/jpet.104.081265","article-title":"Hydrolysis of capecitabine to 5'-deoxy-5-fluorocytidine by human carboxylesterases and inhibition by loperamide","volume":"313","author":"Quinney","year":"2005","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.cbi.2022.110228_bib41","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1080\/17425255.2021.1908262","article-title":"Drug metabolism in the lungs: opportunities for optimising inhaled medicines","volume":"17","author":"Enlo-Scott","year":"2021","journal-title":"Expet Opin. Drug Metabol. Toxicol."},{"key":"10.1016\/j.cbi.2022.110228_bib42","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bcp.2010.09.001","article-title":"Organ-specific carboxylesterase profiling identifies the small intestine and kidney as major contributors of activation of the anticancer prodrug CPT-11","volume":"81","author":"Hatfield","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.cbi.2022.110228_bib43","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1124\/dmd.119.087031","article-title":"Arylacetamide deacetylase enzyme: presence and interindividual variability in human lungs","volume":"47","author":"Gabriele","year":"2019","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.cbi.2022.110228_bib44","doi-asserted-by":"crossref","first-page":"34337","DOI":"10.1074\/jbc.M110.161802","article-title":"Mechanism of activation of PSI-7851 and its diastereoisomer PSI-7977","volume":"285","author":"Murakami","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.cbi.2022.110228_bib45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/jat\/16.5.276","article-title":"Blood cannabinoids. I. Absorption of THC and formation of 11-OH-THC and THCCOOH during and after smoking marijuana","volume":"16","author":"Huestis","year":"1992","journal-title":"J. Anal. Toxicol."},{"key":"10.1016\/j.cbi.2022.110228_bib46","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/clpt.1980.181","article-title":"Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking","volume":"28","author":"Ohlsson","year":"1980","journal-title":"Clin. Pharmacol. Ther."},{"issue":"Suppl 1","key":"10.1016\/j.cbi.2022.110228_bib47","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000056764","article-title":"Lung lining liquid - the hidden depths. The 5th Nils W. Svenningsen memorial lecture","volume":"81","author":"Walters","year":"2002","journal-title":"Biol. Neonate"},{"key":"10.1016\/j.cbi.2022.110228_bib48","series-title":"Controlled Pulmonary Drug Delivery","first-page":"21","article-title":"Pulmonary drug metabolism, clearance, and absorption","author":"Olsson","year":"2011"},{"key":"10.1016\/j.cbi.2022.110228_bib49","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1007\/s40263-018-0578-5","article-title":"A phase I, randomized, double-blind, placebo-controlled, single ascending dose, multiple dose, and food effect trial of the safety, tolerability and pharmacokinetics of highly purified cannabidiol in healthy subjects","volume":"32","author":"Taylor","year":"2018","journal-title":"CNS Drugs"},{"key":"10.1016\/j.cbi.2022.110228_bib50","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1002\/jps.2600630705","article-title":"Physiochemical properties, solubility, and protein binding of delta9-tetrahydrocannabinol","volume":"63","author":"Garrett","year":"1974","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.cbi.2022.110228_bib52","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1124\/dmd.121.000823","article-title":"Prediction of carboxylesterase 1 (CES1)-mediated in vivo drug interaction between methylphenidate and cannabinoids using static and physiologically based pharmacokinetic models","volume":"50","author":"Qian","year":"2022","journal-title":"Drug Metab. Dispos."}],"container-title":["Chemico-Biological Interactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722004331?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009279722004331?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T14:16:18Z","timestamp":1757859378000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009279722004331"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":50,"alternative-id":["S0009279722004331"],"URL":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110228","relation":{},"ISSN":["0009-2797"],"issn-type":[{"type":"print","value":"0009-2797"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Involvement of esterases in the pulmonary metabolism of beclomethasone dipropionate and the potential influence of cannabis use","name":"articletitle","label":"Article Title"},{"value":"Chemico-Biological Interactions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cbi.2022.110228","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110228"}}